Two Sigma Investments’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-107,601
| Closed | -$1.61M | – | 3362 |
|
|
2022
Q4 | $1.61M | Buy |
107,601
+60,599
| +129% | +$839K | 0.01% | 1432 |
|
|
2022
Q3 | $387K | Buy |
+47,002
| New | +$361K | ﹤0.01% | 1886 |
|
|
2021
Q3 | – | Sell |
-211,723
| Closed | -$1.4M | – | 4949 |
|
|
2021
Q2 | $1.4M | Buy |
211,723
+158,648
| +299% | +$1.09M | ﹤0.01% | 2190 |
|
|
2021
Q1 | $389K | Sell |
53,075
-46,910
| -47% | -$405K | ﹤0.01% | 3141 |
|
|
2020
Q4 | $577K | Buy |
+99,985
| New | +$572K | ﹤0.01% | 2407 |
|
|
2020
Q3 | – | Sell |
-154,108
| Closed | -$794K | – | 3777 |
|
|
2020
Q2 | $794K | Buy |
154,108
+140,671
| +1,047% | +$888K | ﹤0.01% | 1686 |
|
|
2020
Q1 | $49K | Buy |
13,437
+3,189
| +31% | +$15.8K | ﹤0.01% | 2933 |
|
|
2019
Q4 | $64K | Buy |
+10,248
| New | +$75.5K | ﹤0.01% | 3555 |
|
|
2018
Q2 | – | Sell |
-1,080
| Closed | -$31K | – | 3821 |
|
|
2018
Q1 | $31K | Sell |
1,080
-1,887
| -64% | -$55.2K | ﹤0.01% | 3073 |
|
|
2017
Q4 | $83K | Buy |
+2,967
| New | +$92.1K | ﹤0.01% | 3008 |
|
|
2015
Q3 | – | Sell |
-9,349
| Closed | -$163K | – | 2945 |
|
|
2015
Q2 | $163K | Sell |
9,349
-249
| -3% | -$4.48K | ﹤0.01% | 2656 |
|
|
2015
Q1 | $139K | Buy |
+9,598
| New | +$105K | ﹤0.01% | 2530 |
|
|
2014
Q3 | – | Sell |
-3,455
| Closed | -$63K | – | 2196 |
|
|
2014
Q2 | $63K | Sell |
3,455
-4,769
| -58% | -$62K | ﹤0.01% | 2079 |
|
|
2014
Q1 | $123K | Sell |
8,224
-7,520
| -48% | -$135K | ﹤0.01% | 1862 |
|
|
2013
Q4 | $290K | Buy |
15,744
+14,536
| +1,203% | +$291K | ﹤0.01% | 1891 |
|
|
2013
Q3 | $25K | Sell |
1,208
-410
| -25% | -$9.39K | ﹤0.01% | 1796 |
|
|
2013
Q2 | $40K | Buy |
+1,618
| New | +$69.2K | ﹤0.01% | 1933 |
|
Two Sigma Investments's AVEO Position: Q1 2023 in Review
Two Sigma Investments sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 107,601 shares — an estimated $1.61M sold.
Two Sigma Investments first reported a position in AVEO in Q2 2013 and held it in 17 quarters. The position peaked at $1.61M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Two Sigma Investments reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Two Sigma Investments sold 107,601 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.61M.
- Two Sigma Investments first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
- Two Sigma Investments's AVEO Pharmaceuticals, Inc. position peaked at $1.61M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.